Eumedica Pharma acquires several anti-psychotic medicines from Janssen Pharmaceutica. October 2013: CMC Benelux advised Eumedica Pharma in the acquisition of the anti-psychotic medicines ORAP®, IMAP®, DIPIPERON®, IMPROMEN® DECANOAS, and IMPROMEN® drops from Janssen Pharmaceutica, enabling Eumedica to expand its worldwide pharma presence.

"We are extremely pleased to be able to add these Janssen medicines to our existing product line, which enlarges our global presence and enables us to pursue new growth opportunities," commented Nicolas Vryghem, CFO Eumedica. "We have been advised in this acquisition by the CMC Consulting Group and are pleased this led to us acquiring these quality products."

Eumedica is an independent pharmaceutical company specialized in the manufacturing and the distribution of niche hospital products that have undeniable therapeutic value. Eumedica has a proven track record in acquiring existing, original drugs and integrating them successfully in their portfolio. The Group is present in the Benelux, France, United Kingdom, Switzerland, Austria and Italy, and currently employs over 100 people. Its products are being distributed in over 25 countries.

Janssen Pharmaceutical Companies are dedicated to addressing and solving the most important unmet medical needs of our time, including oncology (e.g. multiple myeloma and prostate cancer), immunology (e.g. psoriasis), neuroscience (e.g. schizophrenia, dementia and pain), infectious disease (e.g. HIV/AIDS, hepatitis C and tuberculosis), and cardiovascular and metabolic diseases (e.g. diabetes). Driven by their commitment to patients, they develop sustainable, integrated healthcare solutions by working side-by-side with healthcare stakeholders, based on partnerships of trust and transparency. More information can be found at www.janssen-emea.com.









 
Ultime Notizie

CMC Consulting Group Acquired by Management Team in MBO

Munich, Amsterdam April 2, 2014 -- CMC Consulting Group, a leading international healthcare strategy and Mergers & Acquisitions advisory firm, has been acquired by three of the leading directors of the Group (Benjamin Chambon, Ernst Elhorst and Gabriele Brambilla).

Leggi tutto...
 

CMC Partner Mathias Käsebier speaking at the 5th AmCham Business Conference. Atlanta, February 26th 2014, “Transatlantic M&A: Successfully navigating across borders and cultures" is the topic Mathias Käsebier, specialist at CMC Consulting in crossborder M&A deals between the US and Germany, will speak about at the American Chamber Business Conference in Atlanta.

Leggi tutto...
 

Eumedica Pharma acquires several anti-psychotic medicines from Janssen Pharmaceutica. October 2013: CMC Benelux advised Eumedica Pharma in the acquisition of the anti-psychotic medicines ORAP®, IMAP®, DIPIPERON®, IMPROMEN® DECANOAS, and IMPROMEN® drops from Janssen Pharmaceutica, enabling Eumedica to expand its worldwide pharma presence.

Leggi tutto...
 

Hofmeister & Meincke GmbH & Co. KG sold to Fricke Group. Munich, October 15th, 2013. CMC Consulting AG (“CMC”) is pleased to announce that Hofmeister & Meincke GmbH & Co. KG, Bremen, (“H&M”) has been sold to Fricke Group, Heeslingen.

Leggi tutto...
 

Ludwig Frohnhäuser sells Medical Device Trade to Promedia A. Ahnfeldt. Munich, July 2013 - Ludwig Frohnhäuser GmbH in Unterhaching, Germany, has been a medical distributor for three generations.

Leggi tutto...
 

G2D Pharma acquires UVIMAG. Paris, 1st June 2013 - CMC Consulting advised G2D Pharma in the acquisition of UVIMAG towards Laboratoires Zambon.

Leggi tutto...
 

Mediq CombiCare acquired Hodes Medische Speciaalzaken. Utrecht, 12th April 2013 - Mediq CombiCare acquires Hodes Medische Speciaalzaken.Hodes, a medical specialist business, supplies ostomy, incontinence and wound care products. It is a regional player based in Arnhem, with 20 employees. With this acquisition, Mediq CombiCare is strengthening its leading market position.

Leggi tutto...
 

Quies S.A. acquires assets from Laboratoires Bioréance

Leggi tutto...
 
I nostri clienti
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Copyright © 2014 CMC Consulting Group. Tutti i diritti riservati.